NO20084674L - 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser - Google Patents
1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelserInfo
- Publication number
- NO20084674L NO20084674L NO20084674A NO20084674A NO20084674L NO 20084674 L NO20084674 L NO 20084674L NO 20084674 A NO20084674 A NO 20084674A NO 20084674 A NO20084674 A NO 20084674A NO 20084674 L NO20084674 L NO 20084674L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- gastrointestinal disorders
- benzoyl
- phenyl
- butyl
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title abstract 2
- 150000001539 azetidines Chemical class 0.000 title 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 title 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80157706P | 2006-05-18 | 2006-05-18 | |
PCT/SE2007/000482 WO2007136324A1 (en) | 2006-05-18 | 2007-05-16 | 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084674L true NO20084674L (no) | 2009-01-29 |
Family
ID=38723558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084674A NO20084674L (no) | 2006-05-18 | 2008-11-06 | 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser |
Country Status (24)
Country | Link |
---|---|
US (1) | US8106208B2 (es) |
EP (1) | EP2024354B1 (es) |
JP (1) | JP5196381B2 (es) |
KR (1) | KR101429779B1 (es) |
CN (1) | CN101472910B (es) |
AR (1) | AR060956A1 (es) |
AT (1) | ATE525355T1 (es) |
AU (1) | AU2007253666B2 (es) |
BR (1) | BRPI0712405A2 (es) |
CA (1) | CA2652443C (es) |
DK (1) | DK2024354T3 (es) |
ES (1) | ES2373335T3 (es) |
HK (1) | HK1121758A1 (es) |
IL (1) | IL195197A (es) |
MX (1) | MX2008014686A (es) |
MY (1) | MY147474A (es) |
NO (1) | NO20084674L (es) |
PL (1) | PL2024354T3 (es) |
PT (1) | PT2024354E (es) |
RU (1) | RU2439067C2 (es) |
TW (1) | TW200813006A (es) |
UY (1) | UY30356A1 (es) |
WO (1) | WO2007136324A1 (es) |
ZA (1) | ZA200809909B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
EP2061780A4 (en) * | 2006-09-14 | 2010-12-22 | Zalicus Pharmaceuticals Ltd | DIARYLE PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS |
KR101558005B1 (ko) * | 2007-03-08 | 2015-10-06 | 알비레오 에이비 | 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도 |
WO2009135842A1 (en) | 2008-05-08 | 2009-11-12 | Evotec Neurosciences Gmbh | Azetidines and cyclobutanes as histamine h3 receptor antagonists |
EP2629851A1 (en) * | 2010-10-22 | 2013-08-28 | Janssen Pharmaceutica N.V. | Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors |
MX342140B (es) * | 2011-09-30 | 2016-09-14 | Janssen Pharmaceutica Nv | Sal clorhidrato cristalina de (1-(4-fluorofenil)-1h-indol-5-il)-(3 -(4-(tiazol-2-carbonil)piperazin-1-il) azetidin-1-il)metanona y su uso en el tratamiento del dolor y transtornos metabolicos. |
CN104529833B (zh) * | 2014-12-10 | 2016-04-20 | 广东东阳光药业有限公司 | 取代的环丁烷羧酸类化合物及其用途 |
KR102476938B1 (ko) | 2017-12-07 | 2022-12-13 | 기초과학연구원 | 핫전자 기반의 산화물-금속 하이브리드 역촉매 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310066D0 (en) | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Alkyl substituted heterocycles |
GB9310713D0 (en) | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
GB9317104D0 (en) | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
GB9322643D0 (en) | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
GB9325074D0 (en) | 1993-12-07 | 1994-02-02 | Zeneca Ltd | Bicyclic heterocycles |
TW432061B (en) | 1994-08-09 | 2001-05-01 | Pfizer Res & Dev | Lactams |
GB9502644D0 (en) | 1995-02-10 | 1995-03-29 | Zeneca Ltd | Heterocyclic derivatives |
GB9600235D0 (en) | 1996-01-05 | 1996-03-06 | Pfizer Ltd | Therapeutic agents |
GB9601202D0 (en) | 1996-01-22 | 1996-03-20 | Pfizer Ltd | Piperidones |
GB9601680D0 (en) | 1996-01-27 | 1996-03-27 | Pfizer Ltd | Therapeutic agents |
GB9601697D0 (en) | 1996-01-27 | 1996-03-27 | Pfizer Ltd | Therapeutic agents |
GB9714129D0 (en) | 1997-07-04 | 1997-09-10 | Pfizer Ltd | Azetidines |
GB9812037D0 (en) | 1998-06-04 | 1998-07-29 | Pfizer Ltd | Piperidones |
BR9912013A (pt) * | 1998-07-10 | 2001-04-10 | Astrazeneca Ab | Composto, composição farmacêutica, método de tratar uma condição de doença, e, processo para preparar um composto |
GB9922521D0 (en) | 1998-10-07 | 1999-11-24 | Zeneca Ltd | Compounds |
GB9922519D0 (en) | 1998-10-07 | 1999-11-24 | Zeneca Ltd | Compounds |
GB9924141D0 (en) | 1998-10-30 | 1999-12-15 | Zeneca Ltd | Treatment of gastric asthma |
GB9826941D0 (en) | 1998-12-09 | 1999-02-03 | Zeneca Pharmaceuticals | Compounds |
SE0004827D0 (sv) | 2000-12-22 | 2000-12-22 | Astrazeneca Ab | Therapeutic compounds |
SE0103795D0 (sv) | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Compounds and method for the treatment of överactive bladder |
TW200508221A (en) | 2003-06-13 | 2005-03-01 | Astrazeneca Ab | New azetidine compounds |
MX2007015606A (es) * | 2005-06-23 | 2008-02-25 | Astrazeneca Ab | Nuevos derivados de azetidina como antagonistas del receptor de neuroquinina para el tratamiento de enfermedades gastrointestinales. |
WO2006137791A1 (en) * | 2005-06-23 | 2006-12-28 | Astrazeneca Ab | New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
AR056087A1 (es) * | 2005-09-29 | 2007-09-19 | Astrazeneca Ab | Derivados de azetidina como antagonistas de receptores de neuroquina nk |
AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
-
2007
- 2007-05-11 US US11/747,322 patent/US8106208B2/en not_active Expired - Fee Related
- 2007-05-14 TW TW096117067A patent/TW200813006A/zh unknown
- 2007-05-16 MX MX2008014686A patent/MX2008014686A/es active IP Right Grant
- 2007-05-16 PL PL07748146T patent/PL2024354T3/pl unknown
- 2007-05-16 EP EP07748146A patent/EP2024354B1/en not_active Not-in-force
- 2007-05-16 BR BRPI0712405-8A patent/BRPI0712405A2/pt not_active IP Right Cessation
- 2007-05-16 PT PT07748146T patent/PT2024354E/pt unknown
- 2007-05-16 RU RU2008149927/04A patent/RU2439067C2/ru not_active IP Right Cessation
- 2007-05-16 CA CA2652443A patent/CA2652443C/en not_active Expired - Fee Related
- 2007-05-16 CN CN200780022773.8A patent/CN101472910B/zh not_active Expired - Fee Related
- 2007-05-16 DK DK07748146.3T patent/DK2024354T3/da active
- 2007-05-16 ES ES07748146T patent/ES2373335T3/es active Active
- 2007-05-16 WO PCT/SE2007/000482 patent/WO2007136324A1/en active Application Filing
- 2007-05-16 AR ARP070102113A patent/AR060956A1/es not_active Application Discontinuation
- 2007-05-16 AU AU2007253666A patent/AU2007253666B2/en not_active Ceased
- 2007-05-16 UY UY30356A patent/UY30356A1/es unknown
- 2007-05-16 KR KR1020087029057A patent/KR101429779B1/ko not_active IP Right Cessation
- 2007-05-16 AT AT07748146T patent/ATE525355T1/de not_active IP Right Cessation
- 2007-05-16 JP JP2009510922A patent/JP5196381B2/ja not_active Expired - Fee Related
-
2008
- 2008-11-06 NO NO20084674A patent/NO20084674L/no not_active Application Discontinuation
- 2008-11-10 IL IL195197A patent/IL195197A/en not_active IP Right Cessation
- 2008-11-11 MY MYPI20084521A patent/MY147474A/en unknown
- 2008-11-20 ZA ZA200809909A patent/ZA200809909B/xx unknown
-
2009
- 2009-02-23 HK HK09101710.8A patent/HK1121758A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL2024354T3 (pl) | 2012-02-29 |
EP2024354B1 (en) | 2011-09-21 |
EP2024354A1 (en) | 2009-02-18 |
EP2024354A4 (en) | 2009-11-11 |
US20070270398A1 (en) | 2007-11-22 |
RU2439067C2 (ru) | 2012-01-10 |
AU2007253666B2 (en) | 2012-03-15 |
CA2652443A1 (en) | 2007-11-29 |
MY147474A (en) | 2012-12-14 |
AR060956A1 (es) | 2008-07-23 |
JP5196381B2 (ja) | 2013-05-15 |
IL195197A0 (en) | 2009-08-03 |
PT2024354E (pt) | 2011-12-19 |
JP2009537516A (ja) | 2009-10-29 |
BRPI0712405A2 (pt) | 2012-10-16 |
ES2373335T3 (es) | 2012-02-02 |
ATE525355T1 (de) | 2011-10-15 |
CA2652443C (en) | 2014-01-14 |
IL195197A (en) | 2013-10-31 |
MX2008014686A (es) | 2009-02-10 |
WO2007136324A1 (en) | 2007-11-29 |
HK1121758A1 (en) | 2009-04-30 |
RU2008149927A (ru) | 2010-06-27 |
KR101429779B1 (ko) | 2014-08-19 |
KR20090018926A (ko) | 2009-02-24 |
CN101472910B (zh) | 2014-03-26 |
TW200813006A (en) | 2008-03-16 |
DK2024354T3 (da) | 2012-01-16 |
US8106208B2 (en) | 2012-01-31 |
ZA200809909B (en) | 2009-08-26 |
UY30356A1 (es) | 2008-01-02 |
AU2007253666A1 (en) | 2007-11-29 |
CN101472910A (zh) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084674L (no) | 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser | |
NO20063470L (no) | Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
NO20063468L (no) | Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister | |
NO341591B1 (no) | 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt | |
NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
NO20091590L (no) | Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer | |
NO20063597L (no) | Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
NO20062677L (no) | Benzyleteraminforbindelser anvendbare som CCR-5-antagonister | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
NO20084403L (no) | Cykloheksylpyrazol-lactamderivater som inhibitorer av II-beta-hydroksysteroid dehydrogenase I | |
NO20083514L (no) | Heterobicykliske sulfonamidderivater for behandling av diabetes | |
NZ594597A (en) | Substituted piperidines as ccr3 antagonists | |
NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
NO20055688L (no) | Organiske forbindelser | |
NO20076424L (no) | N-koblete heterocykliske antagonister av P2Y1 reseptoren nyttige for behandling av tromboseforstyrrelser | |
NO20084318L (no) | Inhibitorer av II-beta-hydroksystereoid dehydrogenase I | |
NO20076060L (no) | Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister | |
ATE455756T1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
NO20070336L (no) | Indolderivater som histamin-reseptorantagonister | |
ATE459619T1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |